Julian Kager

Title: Innovations by Julian Kager in Fermentation Processes

Introduction

Julian Kager, an accomplished inventor based in Vienna, Austria, holds a significant patent in the field of biotechnology. With his expertise in fermentation processes, he contributes to advancements that enhance the production of recombinant proteins, which are vital in various scientific and medical applications.

Latest Patents

Kager's notable patent is a method for producing a recombinant protein of interest (POI). This innovative process comprises several steps: first, culturing cells in a specialized cell culture medium to express the POI. A key aspect involves adding a feed containing at least one substrate to the cell culture. Furthermore, the invention implements a feeding strategy based on calculating, setting, and optionally controlling the specific substrate uptake rate of the cells during the induction and production phases of the POI. This unique approach aims to maintain the substrate uptake rate close to the maintenance level of the cell culture, ultimately leading to improved yields of the desired protein. The final step involves isolating the POI from the cell culture, making the process efficient and effective.

Career Highlights

Currently, Julian Kager works at Lonza Inc., a reputable company well-known for its contributions to the pharmaceutical and biotechnology industries. His work at Lonza Inc. demonstrates his commitment to advancing biotechnological processes and improving production methods for essential proteins.

Collaborations

Throughout his career, Julian has collaborated with prominent colleagues, including Wieland Reichelt and Christoph Herwig. These partnerships have allowed for a dynamic exchange of ideas and have significantly contributed to the success of Kager's innovative projects.

Conclusion

Julian Kager is a notable figure in the field of biotechnology, recognized for his inventive approach to fermentation processes. His patent not only showcases his innovative spirit but also exemplifies the critical role of collaboration in scientific advancements. As he continues his work at Lonza Inc., Kager is sure to be a driving force in the evolution of recombinant protein production.